Shanghai Meiji Health Science and Technology Co., Ltd

计划入组 95 人 · 首次发布于 2020 年 12 月 3 日

Study of Medication for Nonallergic Rhinitis (NAR) Based on Cluster Analysis

计划入组 80 人 · 首次发布于 2019 年 6 月 28 日

A multicenter, randomized, double-blind, positive-controlled clinical trial to evaluate the efficacy and safety of Compound Yinhua Jiedu Granule in the treatment of influenza (wind-heat syndrome)

Anakinra biosimilar(Shanghai Biomabs Pharmaceuticals Co., Ltd.)

Autologous cell immunotherapy(Shanghai Pharmaceuticals Holding Co., Ltd.)

Thrombomodulin(JCR Pharmaceuticals Co., Ltd.)

Shanghai Pharmaceuticals Holding Co.,Ltd.

China

Shanghai Allist Pharmaceuticals Co., Ltd.

Deciphera Pharmaceuticals (Shanghai) Co., Ltd.

China

Curium Receives Chinese Regulatory Approval to Begin Phase 3 Trial of 177Lu-PSMA-I&T for Metastatic Prostate Cancer

Eisai Advances LEQEMBI Subcutaneous and IV Maintenance Dosing Applications for Alzheimer's Disease

AIM Vaccine Submits 13-Valent Pneumonia Conjugate Vaccine for Approval After Positive Phase III Results